Signs and symptoms depend on the parts of the body affected by the disease.
Ocular involvement usually occurs in up to 70-95% of patients with Behçet’s and manifests as bilateral uveitis, affecting the anterior and/or the posterior part of the eye.
The typical manifestations of ocular disease is retinal vasculitis, occurring when the inflammation affects the vessels of the retina, causing inflammation in the vitreous, macular oedema and occlusion of the blood vessels.
The severe and recurrent nature of the uveitis can lead to permanent and often irreversible ocular tissue damage and subsequently, visual loss.
Behçet’s is an inflammatory condition presumably driven by an abnormal immune response that occurs in genetically predisposed individuals. It’s possible that a viral or bacterial infection may trigger the disorder.
Signs and symptoms of the disease are due to the inflammation of the blood vessels throughout the body.
Behçet’s syndrome can’t be passed on to other people or from parent to child, but genetic factors may increase the likelihood of a person developing the condition. The human leukocyte antigen (HLA)-B51 has been associated with the disease, but it is not used as a diagnostic test.
The diagnosis of Behçet’s is based on clinical criteria, including recurrent oral ulcers, recurrent genital ulcers, ocular lesions and cutaneous lesions. Mouth ulcers are quite common in the population and if patients only have occasional mouth ulcers, it’s very unlikely that they have Behçet’s. There are no specific laboratory tests.
In patients with ocular manifestations, fluorescein angiography is usually performed to demonstrate inflammation of the retinal vessels and areas of vascular occlusion, to monitor the course of the disease and its complications and to evaluate the response to treatment.
The intention of therapy is to control the inflammation and prevent the damage to the retina, and consequently the visual loss.
The treatments are not curative but aim at controlling the immune response which is the reason of the inflammation in the eye.
Options include the use of oral medications, usually starting with systemic steroids to induce rapid response. In view of the nature of the disease, the addition of immunosuppressive drugs is important to allow long term control and minimize the side effects of systemic steroids.
Local therapy is an option for controlling ocular disease and includes the use of steroid devices (Ozurdex and Iluvien).
If not well controlled, Behçet’s can result in long term damage because of the chronic macular oedema, optic nerve involvement and loss of retinal tissue.
Other common complications include abnormal retinal vessels that can bleed and epiretinal membrane. All these complications can affect the vision.
Contact
Ilaria Testi
The London Clinic Eye Centre
119 Harley Street
London W1G 6AU
COPYRIGHT 2026 | Dr ILARIA TESTI | Cookie Policy | Term and Conditions